EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Characterization of the Immune Response after Oral Cholera Vaccination ( OCV ) and Effects of Mycophenolate Mofetil on Priming of this Immune Response—A Randomized, Placebo‐Controlled Trial

Boukje C Eveleens Maarse iD, Aliede E In 't Veld iD, Hendrika W Grievink iD, Manon A A Jansen iD, Matthijs Moerland

Clinical Pharmacology & Therapeutics · 2026

DOI: 10.1002/cpt.70399 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Pharmacology & Therapeutics, 2026. Verfasst von Boukje C Eveleens Maarse und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Human Drug Research, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Cholera, Cholera Vaccines, Immunosuppressive Agents, Mycophenolic Acid. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycophenolate mofetil (MMF) is an immunosuppressive drug widely used by solid organ transplant recipients. Although it is known that MMF suppresses immune responses, its exact effects on specific vaccinations have not been investigated yet. Mucosal vaccinations are increasingly used, such as a cholera vaccination consisting of two oral immunizations (oral cholera vaccination; OCV). This study aimed to investigate the specific immunosuppressive effects of MMF use during the first dose of OCV in a randomized, placebo‐controlled trial in healthy volunteers. Moreover, the study aimed to characterize the immune response provoked by OCV in detail. This randomized, placebo‐controlled, single‐blind trial included 16 healthy volunteers, each receiving two doses of Dukoral® and an intranasal rechallenge. Outcome measures were serum antibody responses (IgA and IgG) and IgA levels in saliva. Additionally, peripheral blood mononuclear cells (PBMCs) of participants were investigated for ex vivo cytokine production and expression of tissue‐specific homing markers after OCV. There were considerable serum IgA and IgG responses after vaccination. MMF‐treated volunteers still showed a significant cholera antibody response, though data suggest a potential suppression by MMF without reaching statistical significance. There was no substantial IgA response in saliva. Investigation of PBMCs from OCV‐treated participants showed a Th2 skewing with increased ex vivo production of TNF, IL‐2, IL‐5, IL‐13, and IL‐22 compared to the placebo group. Taken together, this study provides a framework for future clinical pharmacology studies building on OCV as a challenge model and for further investigation of specific effects of MMF on mucosal vaccination responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholeraCholera VaccinesImmunosuppressive AgentsMycophenolic AcidAdultFemaleHumansMaleYoung AdultAdministration, OralAntibodies, BacterialCytokinesImmunoglobulin AImmunoglobulin GLeukocytes, MononuclearSalivaSingle-Blind MethodVaccination

Substanzen

Antibodies, BacterialCholera VaccinesCytokinesDukoralImmunoglobulin AImmunoglobulin GImmunosuppressive AgentsMycophenolic Acid

Autor:innen und Institutionen

  • Centre for Human Drug Research, Leiden, The Netherlands.
  • Leiden University Medical Centre, Leiden, The Netherlands.

ORCID-Profile: Boukje C Eveleens Maarse, Aliede E In 't Veld, Hendrika W Grievink, Manon A A Jansen

Zitieren

APA

Eveleens Maarse, B. C., In 't Veld, A. E., Grievink, H. W., Jansen, M. A. A., & Moerland, M. (2026). Characterization of the Immune Response after Oral Cholera Vaccination ( OCV ) and Effects of Mycophenolate Mofetil on Priming of this Immune Response—A Randomized, Placebo‐Controlled Trial. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70399

Vancouver

Eveleens Maarse BC, In 't Veld AE, Grievink HW, Jansen MAA, Moerland M. Characterization of the Immune Response after Oral Cholera Vaccination ( OCV ) and Effects of Mycophenolate Mofetil on Priming of this Immune Response—A Randomized, Placebo‐Controlled Trial. Clinical Pharmacology & Therapeutics. 2026. doi:10.1002/cpt.70399

BibTeX
@article{EveleensMaarse2026,
  author = {Eveleens Maarse, Boukje C and In 't Veld, Aliede E and Grievink, Hendrika W and Jansen, Manon A A and Moerland, Matthijs},
  title = {Characterization of the Immune Response after Oral Cholera Vaccination ( OCV ) and Effects of Mycophenolate Mofetil on Priming of this Immune Response—A Randomized, Placebo‐Controlled Trial},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1002/cpt.70399}
}
Kostenlos starten →